Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to disseminate knowledge & skills of Acute Cardiovascular Care.
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our mission is to promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our mission is to reduce the burden of cardiovascular disease through percutaneous cardiovascular interventions.
Improving the quality of life and reducing sudden cardiac death by limiting the impact of heart rhythm disturbances.
Our mission is to improve quality of life and longevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
The ESC Working Groups' goal is to stimulate and disseminate scientific knowledge in different fields of cardiology.
The ESC Councils' goal is to share knowledge among medical professionals practising in specific cardiology domains.
OUR MISSION: TO REDUCE THE BURDEN OF CARDIOVASCULAR DISEASE
The early benefit of nurse-led clinics for patients with coronary heart disease (CHD) is lost after 10 years, research indicates, supporting the view that secondary prevention efforts should be optimized immediately upon diagnosis.
The finding is derived from long-term follow-up of a randomized controlled trial that assessed the impact of nurse-led secondary prevention clinics on total mortality and coronary events (nonfatal myocardial infarction and coronary death). The study cohort comprised 1343 patients, aged up to 80 years, with a diagnosis of CHD.
A previous study found that nurse-led clinics produced significant improvements in lifestyle and medical components of secondary prevention and quality of life 1 year after randomization. And at 4 years, nurse-led clinics were associated with significantly fewer deaths and coronary events.
In the latest report, which appears in the journal Heart, Elizabeth Delaney (University of Aberdeen, UK) and team analyzed study outcomes after ten years of follow-up.
They found that the cumulative deaths rates were 38% and 41% in the intervention and control groups, respectively, a non-significant difference. Rates of coronary events were identical, at 19.1%, in each group.
After adjusting for age, gender, and general practice, the hazard ratios were 0.88 for total mortality and 0.96 for coronary events, neither of which were statistically significant. There were no significant differences in the causes of death at either 4 or 10 years.
Delaney et al say their findings support the view that patients should have secondary prevention optimized without delay upon receiving a diagnosis of CHD.
“Any delay may compromise their medium- to long-term survival,” they write. “It is incumbent upon policy makers and health professionals to ensure that processes of care are organized to permit optimization of secondary prevention for CHD at the very earliest stage.”
In an accompanying editorial, the authors stress the importance of CHD prevention and say it is “well worth doing despite the difficulty.”
“Secondary prevention still glistens as the jewel in the cardiovascular prevention crown,” they write. “Questions about its long-term effectiveness and optimal mix of components remain as a research and clinical priority.”
Read the abstract
© 2017 European Society of Cardiology. All rights reserved